发明公开
EP1268524A2 BINDING PEPTIDES FOR CARCINOEMBRYONIC ANTIGEN (CEA)
有权
肽,DIE CEA(“CARCINOEMBRYONIC ANTIGEN”)BINDEN
- 专利标题: BINDING PEPTIDES FOR CARCINOEMBRYONIC ANTIGEN (CEA)
- 专利标题(中): 肽,DIE CEA(“CARCINOEMBRYONIC ANTIGEN”)BINDEN
-
申请号: EP01923058.0申请日: 2001-04-03
-
公开(公告)号: EP1268524A2公开(公告)日: 2003-01-02
- 发明人: RONDON, Isaac, Jesus , LADNER, Robert, Charles
- 申请人: Dyax Corp.
- 申请人地址: 300 Technology Square,8th Floor Cambridge, MA 02139 US
- 专利权人: Dyax Corp.
- 当前专利权人: Dyax Corp.
- 当前专利权人地址: 300 Technology Square,8th Floor Cambridge, MA 02139 US
- 代理机构: Stark, Amanda Jane
- 优先权: US541345 20000403
- 国际公布: WO01074849 20011011
- 主分类号: C07K7/06
- IPC分类号: C07K7/06 ; C07K7/08 ; G01N33/534 ; G01N33/574 ; A61K38/08 ; A61K38/10 ; C12N15/63 ; A61P35/00
摘要:
The present invention provides binding moieties for CEA, which have a variety of uses wherever detecting, isolating or localizing CEA, and particularly CEA as opposed to cross-reactive antigens such as NCA, is advantageous. Particularly disclosed are synthetic, isolated polypeptides capable of binding CEA, which is overexpressed in adenocarcinomas of endodermally derived digestive system epithelia and fetal colon. Such polypeptides and disclosed derivatives are useful, e.g., as imaging agents for CEA-expressing tumors.
公开/授权文献
- EP1268524B1 BINDING PEPTIDES FOR CARCINOEMBRYONIC ANTIGEN (CEA) 公开/授权日:2005-11-02
信息查询